—CMS
— • —
$79.38
P/E
22.35
PEG
0.04
FCF Yield
—
Rev Growth YoY
+1295.0% YoY
Gross Margin
3186.1%
Health Score
4/10
D/E Ratio
2.07
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits full company context. Based on available financial data, this appears to be a company experiencing explosive early-stage or transformational revenue growth, with a current price of $79.38. Without a market capitalisation figure, a precise cap-tier classification cannot be confirmed, though the valuation ratios and price level are consistent with a small-to-mid cap profile.
Financial Health
**Score: 4/10** The financial profile presents a striking contradiction between headline metrics and underlying structural concerns. Gross margin of 3,186.1% and net margin of 1,317.0% appear extraordinarily elevated — figures that, while reported, likely reflect a non-standard revenue or cost recognition structure and should be interpreted with caution rather than as evidence of genuine profitability at scale...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 3,186.1% and net margin of 1,317.0% are arithmetically unusual and may indicate non-standard accounting, restatements, or data classification errors that obscure true profitability. - **DEBT:** Debt/equity of 2.07x represents high leverage, creating refinancing risk especially in a rising-rate environment. - **LIQUIDITY:** Current ratio of 0.98x falls below 1.0x, meaning current liabilities are not fully covered by current assets — a potential short-term solvency concern. - **CASH FLOW OPACITY:** Free cash flow is unavailable, making it impossible to verify whether the reported earnings translate into real cash generation. - **TECHNICALS:** A confirmed death cross (50-day MA crossing below 200-day MA) and a bearish MACD signal indicate negative price momentum — the trend is working against buyers at this level. ---...